50332-66-6 Usage
Description
3-NITRO-4-QUINOLINOL, also known as 3-Nitro-4-hydroxyquinoline, is an organic compound with the CAS number 50332-66-6. It is a tan solid and is primarily used in the field of organic synthesis due to its unique chemical properties.
Uses
Used in Organic Synthesis:
3-NITRO-4-QUINOLINOL is used as a synthetic building block for the creation of various organic compounds. Its chemical structure allows it to participate in a range of reactions, making it a valuable component in the synthesis of complex molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 3-NITRO-4-QUINOLINOL is used as an intermediate in the development of new drugs. Its unique chemical properties enable it to be a key component in the synthesis of various pharmaceutical compounds, potentially leading to the discovery of novel therapeutic agents.
Used in Chemical Research:
3-NITRO-4-QUINOLINOL is also utilized in chemical research as a model compound to study various reaction mechanisms and to understand the behavior of similar molecules. This helps researchers in the development of new synthetic methods and the optimization of existing ones.
Used in Material Science:
In the field of material science, 3-NITRO-4-QUINOLINOL can be used as a component in the development of new materials with specific properties. Its unique chemical structure may contribute to the creation of materials with enhanced characteristics, such as improved stability or reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 50332-66-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,0,3,3 and 2 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 50332-66:
(7*5)+(6*0)+(5*3)+(4*3)+(3*2)+(2*6)+(1*6)=86
86 % 10 = 6
So 50332-66-6 is a valid CAS Registry Number.
InChI:InChI=1/C9H6N2O3/c12-9-6-3-1-2-4-7(6)10-5-8(9)11(13)14/h1-5H,(H,10,12)
50332-66-6Relevant articles and documents
IMIDAZOQUINOLINE-TYPE COMPOUNDS AND USES THEREOF
-
Paragraph 0012; 0092; 0093; 00101, (2021/10/11)
Provided in the present disclosure are imidazoquinoline-type compounds, methods for their preparation, pharmaceutical compositions thereof and their use, wherein the imidazoquinoline-type compounds, upon local administration, form depots inducing cell mediated immune response while mitigating a systemic proinflammatory immune response.
LOCALLY ACTING TOLL-LIKE RECEPTOR 7 (TLR7) AND/OR TLR8 AGONIST IMMUNOTHERAPY COMPOUNDS AND THEIR USES
-
Paragraph 0030; 0031; 00172-00175; 00181-00182, (2020/10/19)
Provided in the present disclosure are immunotherapy compounds, pharmaceutical compositions thereof and their use, wherein the immunotherapy compounds, upon local administration, form depots inducing cell mediated immune response while mitigating a systemic proinflammatory immune response.
SUBSTITUTED IMIDAZOQUINOLINES AS AGONISTS OF TLR7
-
Page/Page column 41; 42, (2019/04/10)
The invention relates to imidazoquinoline derivatives and to pharmaceutical compositions containing the imidazoquinoline derivatives. The imidazoquinoline derivatives of the invention are useful as toll-like receptor agonists, in particular agonists of TLR7, and promote induction of certain cytokines.
